FIELD: biotechnology.
SUBSTANCE: disclosed is a cryopreservation medium for mammalian immune cells containing about 1% to 10% wt./vol. of dimethyl sulphoxide (DMSO), from about 0.25% to 5% wt./vol. disaccharide and human serum albumin, as well as methods for cryopreservation of mammalian immune cells using said medium and a kit containing it.
EFFECT: frozen and thawed cells using the media and methods of the present invention preserve high survival rate, which enables to use the cells for various applications, including, for example, methods of adaptive cell transfer.
44 cl, 15 dwg, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CELL CRYOPRESERVATION, ARTIFICIAL CELL CONSTRUCTS OR THREE-DIMENSIONAL TISSUE COMPLEXES | 2010 |
|
RU2573307C2 |
| COMPOSITION AND METHODS OF CRYOPRESERVATION OF HUTC CELLS | 2017 |
|
RU2748057C2 |
| UNGULATE EMBRYO CRYOPRESERVATION | 2016 |
|
RU2730597C2 |
| METHOD FOR CRYOPRESERVATION OF PREPARED TISSUE OF MAMMALIA OR CULTIVATED EQUIVALENT OF TISSUE AND DEVICE FOR ITS REALIZATION | 1996 |
|
RU2178865C2 |
| METHOD FOR TREATING DISEASES | 2006 |
|
RU2322264C1 |
| ARTIFICIAL KIDNEY PRECURSOR AND METHOD FOR MANUFACTURING IT | 2009 |
|
RU2511395C2 |
| METHOD FOR CATTLE OOCYTE FREEZING | 2018 |
|
RU2707252C1 |
| CRYOPRESERVING SOLUTION NOT CONTAINING DMSO AND ITS PRODUCTION METHOD AND USE | 2020 |
|
RU2785227C1 |
| MATERIALS AND METHODS FOR CANCER TREATMENT | 2019 |
|
RU2787828C2 |
| ENRICHMENT WITH CELLS CO-EXPRESSING NKX6.1 AND C-PEPTIDE OBTAINED IN VITRO FROM STEM CELLS | 2018 |
|
RU2829777C2 |
